Evidence map›Paper›PMID 21479246›Full record

ArticlePloS one2011

Use of the ODD-luciferase transgene for the non-invasive imaging of spontaneous tumors in mice.

Scott J Goldman, Elizabeth Chen, Robert Taylor, Sheng Zhang, Whitney Petrosky, Michael Reiss, Shengkan Jin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Non-invasive Reporter Gene Imaging of Cell Therapies, including T Cells and Stem Cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Review
  5. How Non-invasiveFrontiers in physiology · 2020
    Review
  6. Review
  7. Review
  8. Targeting melanoma with front-line therapy does not abrogate Nodal-expressing tumor cells.Laboratory investigation; a journal of technical methods and pathology · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Scott J GoldmanDepartment of Pharmacology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey, United States of America.
Elizabeth Chen
Robert Taylor
Sheng Zhang
Whitney Petrosky
Michael Reiss
Shengkan Jin
Rutgers Cancer Institute of New JerseySecond Xiangya Hospital of Central South University · CN

Funding

The Role of Autophagy in TumorigenesisR01CA116088 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI JIN, SHENGKAN VICTOR · 2007 to 2010
$874k
NCI NIH HHS 1R01CA116088NCI NIH HHS BC060538NCI NIH HHS R01 CA116088
6 · The paper itself

Abstract

backgroundIn humans, imaging of tumors provides rapid, accurate assessment of tumor growth and location. In laboratory animals, however, the imaging of spontaneously occurring tumors continues to pose many technical and logistical problems. Recently a mouse model was generated in which a chimeric protein consisting of HIF-1α oxygen-dependent degradation domain (ODD) fused to luciferase was ubiquitously expressed in all tissues. Hypoxic stress leads to the accumulation of ODD-luciferase in the tissues of this mouse model which can be identified by non-invasive bioluminescence measurement. Since solid tumors often contain hypoxic regions, we performed proof-of-principle experiments testing whether this transgenic mouse model may be used as a universal platform for non-invasive imaging analysis of spontaneous solid tumors. METHODS AND MATERIALS: ODD-luciferase transgenic mice were bred with MMTV-neu/beclin1+/- mice. Upon injection of luciferin, bioluminescent background of normal tissues in the transgenic mice and bioluminescent signals from spontaneously mammary carcinomas were measured non-invasively with an IVIS Spectrum imaging station. Tumor volumes were measured manually and the histology of tumor tissues was analyzed.

conclusionOur results show that spontaneous mammary tumors in ODD-luciferase transgenic mice generate substantial bioluminescent signals, which are clearly discernable from background tissue luminescence. Moreover, we demonstrate a strong quantitative correlation between the bioluminescent tumor contour and the volume of palpable tumors. We further demonstrate that shrinkage of the volume of spontaneous tumors in response to chemotherapeutic treatment can be determined quantitatively using this system. Finally, we show that the growth and development of spontaneous tumors can be monitored longitudinally over several weeks. Thus, our results suggest that this model could potentially provide a practical, reliable, and cost-effective non-invasive quantitative method for imaging spontaneous solid tumors in mice.

Indexed as

AnimalsApoptosis Regulatory ProteinsBeclin-1Cell HypoxiaDiagnostic ImagingFemaleGenetic Predisposition to DiseaseHypoxia-Inducible Factor 1, alpha SubunitLuciferasesMammary Neoplasms, ExperimentalMammary Tumor Virus, MouseMiceMice, TransgenicPrecancerous ConditionsProtein Structure, TertiaryRemission InductionApoptosis Regulatory ProteinsBeclin-1Becn1 protein, mouseHypoxia-Inducible Factor 1, alpha SubunitLuciferases

Identifiers

PMID21479246
PMCPMC3066234
OpenAlexW2095495225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.